High prevalence of BLAOXA-23 in oligoclonal carbapenem-resistant acinetobacter baumannii from siriraj hospital, Mahidol University, Bangkok, Thailand

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 41, Issue 3, 2010, Pages 625-635

  Thapa, Badri ^a   Tribuddharat, Chanwit ^a   Srifuengfung, Somporn ^a   Dhiraputra, Chertsak ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

A. baumannii; Carbapenem resistance; CRAB; lactamase gene

Indexed keywords

BETA LACTAMASE; BETA LACTAMASE OXA 23; BETA-LACTAMASE OXA-23; CARBAPENEM DERIVATIVE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANTIBIOTIC RESISTANCE; ARTICLE; DISK DIFFUSION; DRUG EFFECT; ENZYMOLOGY; GENETIC MARKER; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PLASMID; THAILAND;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; BETA-LACTAMASES; CARBAPENEMS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, BACTERIAL; GENETIC MARKERS; HUMANS; PLASMIDS; THAILAND;

EID: 77954740522     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Adams MD, Goglin K, Molyneaux N, et al. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 2008; 190: 8053-64.
2. Ambler RP, Coulson AF, Frere JM, et al. A standard numbering scheme for class A β-lactamases. J Biochem 1991; 276: 269-72.
3. Barbolla RE, Centron D, Martino AD, et al. Identification of an epidemic carbapenemresistant Acinetobacter baumannii strain at hospitals in Buenos Aires City. Diag Microbiol Infect Dis 2003; 45: 261-4.
4. Bergogne-Berezin E, Towner KJ. Acinetobacter spp as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 1996; 9: 148-65.
5. Bou G, Cervero G, Dominguez MA, Quereda C, Martinez-Beltra J. Characterization of a nosocomial outbreak caused by a multiresistant Acinetobacter baumannii strains with a carbapenem-hydrolyzing enzyme: High-level carbapenem resistance in A. baumannii is not due solely to the presence of β-lactamases. J Clin Microbiol 2000; 38: 3299-05.
6. Bouvet PJM, Grimont PAD. Identification and biotyping of clinical isolates of Acinetobacter. Ann Inst Pasteur Microbiol 1987; 138: 569-78.
7. Centers for Disease Control (CDC). Nosocomial infection surveillance 1984. CDC Summ 1987; 35: 17SS-29SS.
8. Chaiwarith R, Mahattanaphak S, Boonchoo M, Supparatpinyo K, Sirisanthana K. Pandrug-resistant Acinetobacter baumannii at Maharaj Nakorn Chaingmai Hospital. J Infect Dis Antimicrob Agents 2005; 22: 1-8.
9. th informational supplement. CLSI document M100-S15. Wayne, PA: CLSI, 2005.
10. Dalla-Costa LM, Coelho JM, Souza HA, et al. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the OXA-23 enzyme in Curitiba, Brazil. J Clin Microbiol 2003; 41: 3403-6.
11. Davies J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375-82.
12. Dijkshoorn L, van Dalen R, van Ooyen A, et al. Endemic Acinetobacter in intensive care units: epidemiology and clinical impact. J Clin Pathol 1993; 46: 533-6.
13. Hansen M, Hallden C, Sall T. Error rates and polymorphism frequencies for three RAPD protocols. Plant Mol Biol Rep 1998; 16: 139-46.
14. Heritier C, Dobouix A, Poirel L, Marty N, Nordmann P. A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem hydrolyzing oxacillinase OXA-58. J Antimicrob Agents Chemother 2005; 55: 115-8.
15. Jamulitrat S, Thongpiyapoom S, Suwalak N. An outbreak of imipenem-resistant Acinetobacter baumannii at Songklanagarind Hospital: the risk factor and patient prognosis. J Med Assoc Thai 2007; 90: 2181-91.
16. Jeon BC, Jeong SH, Bae IK, et al. Investigation of a nosocomial outbreak of imipenemresistant Acinetobacter baumannii producing the OXA-23 β-lactamase in Korea. J Clin Microbiol 2005; 43: 2241-5.
17. th Annual Meeting of Infectious Disease Association of Thailand, Oct 4-7, 2003.
18. Manuel RJ, Shin GY, Farrag N, Holliman R. Endemic carbapenem-resistant Acinetobacter baumannii in a London hospital. J Antimicrob Chemother 2003; 52: 141-2.
19. Mendes RE, Bell JM, Turnidge J D. Castanheira M, Jones RN. Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemase among Acinetobacter spp in Asia-Pacific nations: report from SENTRY surveillance program. J Antimicrob Chemother 2009; 63: 55-9.
20. Naas T, Levy M, Hirschauer C, Marchandin H, Nordmann P. Outbreak of carbapenem-resistant Acinetobacter baumannii producing the carbapenemase OXA-23 in a tertiary care hospital of Papeete, French Polynesia. J Clin Microbiol 2005; 43: 4826-9.
21. Naas T, Nordmann P. OXA-type-β-lactamases. Curr Pharm Des 1999; 5: 865-79.
22. Nuimsup PR, Boonkerd N, Tansawai U, Tiloklurs M. Carbapenem resistant Acinetobacter baumannii producing OXA23 in Thailand. J Infect Dis 2009; 62: 152-4.
23. Paton R, Miles RS, Amyes SGB. ARI-1: β lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents 1993; 2: 81-8.
24. Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826-36.
25. Ruiz M, Marti S, Fernandex-Cuenca F, Pascual A, Vila J. High prevalence of carbapenemhydrolyzing oxacillinase in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain. Clin Microbiol Infect 2007; 13: 1992-8.
26. Scott P, Deye G, Srinivasan A, et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007; 44: 1577-84.
27. Surasarang K, Narksawat K, Danchaivijitr S, et al. Risk factors for multi-drug resistant Acinetobacter baumannii nosocomial infection. J Med Assoc Thai 2007; 90: 1633-9.
28. Tribuddharat C, Tiensasitorn C, Techachaiwiwat W, et al. In vitro activity of polymyxin B and polymyxin E against multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumannii. J Infect Dis Antimicrob Agents 2003; 20: 135-7.
29. Turton JF, Ward ME, Woodford N, et al. The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett 2006; 258: 72-7.
30. Vila J, Marti S, Sanchez-Ce'spedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother 2007; 59: 1210-5.
31. Villegas MV, Kattan JN, Correa A, et al. Dissemination of Acinetobacter baumannii clones with OXA-23 carbapenemase in Colombian hospitals. J Antimicrob Agents Chemother 2007; 51: 2001-4.
32. Visanu T, Somporn S, Luckna S, et al. Skin flora of patients in Thailand. Am J infect Control 2003; 31: 80-4.
33. Yum JH, Yi K, Lee H, et al. Molecular characterization of metallo-β-lactamases producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integron carrying blaVIM-2 cassettes. J Antimicrob Chemother 2002; 49: 837-40.